Workshop focused on strengthening sterile processing standards, infection prevention, and CSSD best practices in healthcare settings
The company’s Growth Portfolio delivered $6.2 billion in revenue
Lifts full-year outlook as obesity drug boom accelerates
Rahul Bhatnagar succeeds Aditya Narayan, who completed a decade-long distinguished tenure
The renewal covers two versions of the IQOS device and three HEETS tobacco variants
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership
Subscribe To Our Newsletter & Stay Updated
